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ABSTRACT
Autophagy is an immune effector response against a variety of
intracellular pathogens, including Mycobacterium tuberculosis.

Mycobacteria

survive in macrophages by blocking maturation of the phagosome. Induction of
autophagy by the T helper 1 (Th1) cytokine IFN-γ, or amino acid starvation,
enables macrophages to overcome the phagosome maturation block and
impedes mycobacterial survival. This study investigates the role of T helper 2
(Th2) cytokines Interleukin 4 (IL-4) and Interleukin 13 (IL-13) in autophagy in
macrophages and their ability to eliminate intracellular mycobacteria. The Th2
cytokines abrogated autophagy and autophagy-induced transfer of mycobacteria
into lysosomal compartments, thus enhancing mycobacterial survival within
infected macrophages.

In murine and human macrophages, inhibition of

starvation-induced autophagy by IL-4 and IL-13 was dependent on Akt signaling,
whereas the inhibition of IFN-γ-induced autophagy was Akt independent and
signal transducer and activator of transcription 6 (STAT6) dependent. These
findings establish a mechanism through which Th1-Th2 polarization differentially
influences the immune control of intracellular pathogens.
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1. INTRODUCTION
1.1. Overview of tuberculosis
1.1.1. Epidemiology
The facultative intracellular pathogen Mycobacterium tuberculosis (MTB)
is the etiological agent of tuberculosis (TB), a disease of considerable social and
economic impact globally since it is the principal cause of death from any single
bacterial infection.

MTB infects more than a billion people worldwide and,

according to the World Health Organization (WHO), 8-10 million new cases arise
annually. Of the newly infected, 2-3 million die each year [1]. The primary route
of TB infection is through the inhalation of aerosolized droplets containing the
MTB bacteria that escape from the lungs of individuals with the active disease.
After inhalation, the bacteria are able to penetrate the alveoli of the respiratory
tract of the uninfected individual [2]. Ultimately, the bacteria reach the distal
regions of the lung, where in most cases, the infection is contained after
formation of a granuloma, the culmination of a T-helper 1 (Th1)-biased adaptive
immune response.

This results in a latent infection without any detectable

symptoms; however, about 10% of infected individuals remain susceptible to
developing the active disease, which results in irreversible lung destruction [3].
The latent infection can be reactivated when the host immune response is
compromised, as in malnutrition, steroid therapy, and old age; or, in parallel
diseases such as diabetes, leukemia, and HIV [4]. Understanding the processes
involved in granuloma formation and containment of the bacteria is essential in
the development of new treatments and vaccine strategies against tuberculosis.
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The rise of multiple drug-resistant (MDR) strains of TB has compounded
the deadly synergistic effect of co-infection of TB in HIV infected individuals.
Drug-sensitive TB has been treated with combination therapy for over half of
century, as a course of therapy that uses only single drugs can result in the rapid
development of resistance and treatment failure [5]. In addition, when treatment
compliance is compromised, as is repeatedly the case, newly resistant strains
can easily emerge [6]. The standard treatment course for TB involves the use of
first-line drugs for six months. The use of second-line drugs may be necessary
to help prevent drug resistance during therapy [7]. Although the individual is
considered cured after six months of multiple drug treatment, a 2-3% probability
of relapse still exists. The standard treatment for latent TB is six to nine months
of single drug therapy [7]. These anti-tuberculosis treatments, along with the use
of directly observed therapy, where trained personnel monitor the patient taking
each dose of anti-tuberculosis medication, have lead to superior treatment
outcomes and a decline in the overall spread and incidence of TB and MDR TB
[8-10]. However, treatment of TB has led to an increase in deaths arising from
liver injury associated with the use of some of the anti-tuberculosis drugs [11].
Furthermore, reports also indicate that in places with high occurrence of HIV
extensively drug-resistant strains of TB have emerged; these TB strains are
resistant to nearly all second-line drugs used to treat TB [12, 13]. As a result, the
synergism between TB and HIV and the appearance of drug-resistant varieties of
TB, which unaffected by an increasing list of anti-TB agents, represent a critical
health concern and a significant global emergency.
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Currently, there are no

effective vaccines against TB; therefore, understanding the process involved in
the molecular and cellular machinery used by both pathogen and host is urgently
needed as a basis for development of more effective vaccines and treatments to
prevail in the fight against tuberculosis.
1.1.2. Pathogenesis
Mycobacterium tuberculosis infection begins when the bacilli reach the
pulmonary alveoli, invade, and subsequently replicate within the endosomal
compartments

of

the

alveolar

macrophage

[14,

15].

Under

natural

circumstances, the alveolar macrophage ingests the mycobacterial bacilli, which
then are confined in phagosomes [16].

T lymphocytes, B lymphocytes, and

fibroblasts participate to form a granuloma which surrounds the infected
macrophage.

The

granuloma

functions

to

prevent

dissemination

of

mycobacteria, as well as to provide a local environment for communication
between cells of the immune system.

Within the granuloma, T lymphocytes

secrete cytokines, including IFN-γ, which activate the infected macrophage to
destroy the bacteria within [16].

However, tuberculosis lingers in the human

populations due to the ability of mycobacteria to evade innate host killing
mechanisms, which allows it to survive in the alveolar phagocytic cells of the lung
[17]. Therefore, Mycobacterium tuberculosis persists as a thriving intracellular
pathogen.
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1.2. Cellular innate immune system and tuberculosis
1.2.1. Macrophages
Macrophages are crucial effector cells of the innate microbicidal
machinery. They are able to ingest Mycobacterium tuberculosis, an intracellular
pathogen, and confine it to a phagosomal compartment. Subsequently, if the
macrophage is activated, the mycobacteria-containing phagosomes fuse with
lysosomes, in a process known as phagosome maturation, for the killing of the
internalized pathogens (Figure 1.1).

The elimination of mycobacteria via

phagosome maturation occurs through multi-tiered mechanisms, including
reactive oxygen intermediates, reactive nitrogen intermediates, acidification of
the phagosome, and proteolysis of bacteria in the phagolysosome. In contrast, if
the alveolar macrophage is not activated, the internalized bacilli alter the
phagosomes to preclude normal phagosome maturation to phagolysosomes and
avoid terminal endocytic/lysosomal organelles. This action allows the bacilli to
survive and multiply within the phagosomes by escaping direct bactericidal
mechanisms of the host cell and eluding efficient antigen presentation [18]
(Figure 1.1).

Some of the ways MTB persists in the infected macrophage

include: 1) inhibition of phagosome-lysosome fusion (phagosome maturation
arrest) [19, 20], 2) disruption of actin-dependent recruitment of iNOS to the
vicinity of the phagosome [21], 3) expression of detoxifying and anti-oxidant
agents [22-24], and 4) protection by the components of the lipid-rich envelope
[25]. Phagosome maturation arrest is seen as a major pathogenic determinant of
MTB [18] and is the focus of our investigation.

4

1.2.2. Dendritic Cells
Dendritic cells (DCs) journey through peripheral tissues and are essential
for the induction of cellular immunity against intracellular pathogens, including
mycobacteria [26].

DCs have been demonstrated to be the major antigen

presenting cells (APC) for the initiation of primary T cell responses, and as the
initial source of IL-12 during microbial infections [27-29]. The interaction of DCs
with naïve T cells also leads to the production of IFN-γ [30], a vital cytokine in the
control of mycobacterial infections, initiating a cross-talk between T cells and
other cells of the immune response, notably macrophages. Human or murine
myeloid DCs infected with Mycobacterium tuberculosis or Mycobacterium bovis
bacillus Calmette-Guerin (BCG) induce a synchronized program of cell
maturation and an elevation of IL-12 levels [31, 32]. In addition, the transfer of
BCG-infected DCs into mice results in a rapid IFN-γ rise by T cells in response to
mycobacterial antigens [31]. This rapid IFN-γ response is also seen using M.
tuberculosis-infected DCs [33]. Therefore, DCs increase the ability of immune
cells to control mycobacterial replication.
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lysosome

phagosome

phagolysosome

Mtb-containing
phagosome

Figure 1.1. Phagocytosis and Phagosome Maturation Arrest in
Macrophages.
During phagocytosis, mycobacteria are trapped in a phagosome. The
phagosome undergos conversion, known as phagosomal maturation,
accomplished through fusion with lysosome, forming phagolysosome for
degradation. Effective phagocytosis therefore requires mycobacterial ingestion
and phagosomal maturation. Mycobacterium tuberculosis (MTB) survival is due
to its ability to manipulate and arrest phagosome maturation. Here mycobacteria
thrive and persist.
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1.3. Role of cytokines in the immune response to mycobacteria
1.3.1. Th1 cell-mediated response
Th1 cells, a subset of CD4 T cells characterized by the production of IFNγ, play an important role in the development of resistance to intracellular
pathogens [34, 35], primarily through the production of macrophage-activating
cytokines.

The Th1 cytokine IFN-γ has been identified as a key cytokine

controlling mycobacterial infections and is produced by both CD4 and CD8 T
cells [36, 37] in infected individuals as well as by NK cells [38, 39]. To date, IFNγ knockout (GKO) mice are among the most susceptible to challenge with
virulent MTB [40, 41], and individuals defective in genes for IFN-γ or the IFN-γ
receptor are prone to serious mycobacterial infections [42]. Reports also indicate
that professional APC, along with T cells and NK cells, are a source of IFN-γ [4345].

IL-12 and microbial stimulation, alone or in combination, are the most

effective inducers of IFN-γ production by APCs and T cells [46].

In IFN-γ-

activated macrophages, the phagolysosome maturation block induced by M.
tuberculosis is released [47].

The production of IFN-γ by APCs has been

demonstrated mainly in vitro with the use of cultured DCs [48]; however, recent
studies using intact intracellular pathogens

have now provided additional

evidence for the production of APC-derived IFN-γ by in vivo murine model
systems [49, 50]. These data demonstrate the vital role of the Th1 cytokine IFNγ in immunity against mycobacteria.
Once mycobacteria are deposited in the lungs, they have a 3-day lag
period when they do not grow; subsequently, they grow with an average of a 28 h
doubling time and reach approximately 5 logs by 20 days. The cessation of
7

bacterial growth correlates with the arrival of IFN-γ-producing antigen specific
major histocompatibility complex (MHC) class II-restricted T cells [51]. Genetic
defects in the receptors for IL-12 and IFN-γ increase susceptibility to progressive
mycobacterial disease [52-54], while treatment with TNF-α-specific monoclonal
antibodies, used in the treatment of inflammatory disorders such as rheumatoid
arthritis and Crohn’s disease, can result in latent tuberculosis becoming an active
infection [55, 56]. Mice genetically deficient in IFN-γ (GKO mice) are able to form
granulomas, however, they fail to produce nitric oxide and, thus, are unable to
restrict intracellular growth of the bacilli [41]. Similarly, IL-12 increases protection
against mycobacterial infection in susceptible BALB/c mice, but it is unable to do
the same in GKO mice. These data demonstrate that the protective effects of IL12 are dependent on IFN-γ [57]. In humans, dendritic cells also promote IFN-γ
release from natural killer (NK) T cells, a major source of early IFN-γ in
tuberculosis pleurisy [58]. Furthermore, lymphocytes in the lungs of patients with
pulmonary tuberculosis typically have a Th1 phenotype, secreting IFN-γ IL-12
and TNF-α [59, 60]. Therefore, the role of Th1 cytokines in the immunity against
tuberculosis is essential.
1.3.2. Th2 cell-mediated response
Th2 cells, subset of CD4 T cells characterized by the production of IL-4
and IL-13, play an important role in the protection against extracellular bacteria
[61]. In contrast to the beneficial effects of Th1 cytokines, there is currently much
speculation about the role of Th2 cytokines in the response to Mycobacterium
tuberculosis.

A Th1 response develops rapidly following exposure to M.

tuberculosis [62]. However, studies show that a Th2 response also develops,
8

abating the efficacy of Th1 cytokines and promoting immunopathology [63, 64].
Conventional views of the role of IL-4 in TB indicate that it has a useful antiinflammatory role, or that it is merely a late consequence of progressive disease
[65]. However, some studies indicate that the IL-4 response in tuberculosis is not
just a by-product of infection, but that it is actively involved in reducing protection
and increasing immunopathology.

Studies have shown that pre-existing Th2

activity against some components of M. tuberculosis prior to infection leads to
increased immunopathology [66, 67]. Other studies show that the absence of IL4 in IL-4-/- gene knock-out mice leads to diminished bacterial growth [68]. In
addition, it has been shown that IL-4 has the ability to downregulate macrophage
activation [69]. Furthermore, the hypervirulent strains of M. tuberculosis promote
secretion of IL-4 and IL-13 by infected human monocytes [70].

These

characteristics suggest IL-4 is an early potential player in the events that
determine whether the infection becomes latent or progressive. The findings
also raise important questions regarding the role of cytokines, especially in the
context of Th1 versus Th2, in regulating the immune response to pathogens.
Therefore, it is possible that Th2 cytokines are detrimental in the response
against Mycobacterium tuberculosis.
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1.4. Phagosome maturation in macrophages
Macrophages are key effector cells in the innate defense system that seek
and subsequently eliminate bacterial pathogens.
microorganisms is primarily by phagocytosis.

Elimination of invading

Phagocytosis begins by the

clustering of surface receptors and their interaction with their associated ligand.
A variety of phagocytic receptors can recognize innate components of the
pathogen surface, or pathogen-associated molecular patterns [71-74].

Other

phagocytic receptors recognize an exogenous, host-derived ligand, or opsonin,
that adheres to the pathogen surface. Members of the integrin family, CR3 and
CR4, are complement receptors that recognize primarily complement-coated
pathogens. Fcγ receptors (FcγRs), bind to IgG-opsonized pathogens. Once
formed, the phagosome steadily matures, by way of intracellular signals, and
sequentially acquires microbicidal and degradative properties [75-77] by a
process referred to as phagosome maturation [78]. The early phagosome is able
to fuse with early endosome (pH 6.1) to form an intermediate phagosome,
intermediate phagosome fuses with late endosome (pH 5.5–6.0), and late
phagosomes with lysosomes to produce a phagolysosome [79-82] (Figure 1.1).
Consequently, these fusion events transform the phagosomal lumen into a highly
acidic and oxidizing environment, filled with a variety of hydrolytic enzymes that
can degrade its content [83, 84]. Newly synthesized MHC class II molecules
pass through the acidified vesicles and bind peptide fragments of the antigen,
transporting them to the cell surface for presentation to T cells [85]. Specific
markers identify the stage of development during phagosome maturation
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(Table 1). Therefore, the phagocytic compartments of the macrophages are a
significant component in the innate response against invading pathogens.

11

Organelle

Markers

Sorting endosome; early
phagosome

EEA-1, Rab5, PI(3)P, syntaxin-13, transferrin
receptor, VAMP3

Late endosome; late
phagosome

Rab7, Rab9, mannose-6-phosphate receptor,
syntaxin-7, LAMPs, LBPA

Lysosome; phagolysosome

LAMPs, mature cathepsin D, CD63

Table 1. Molecular Markers of Phagosome Maturation.
EEA-1 (Early endosomal antigen 1); PI(3)P (Phosphatidylinositol-3-phosphate);
VAMP3 (Vesicle-associated membrane protein 3 (cellubrevin)); LAMPs
(Lysosomal-associated membrane proteins ); LBPA (Lyso-bisphosphatidic acid);
CD63 (cluster of differentiation63, LAMP3).
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1.4.1. Mycobacteria inhibit phagosome maturation
A significant factor in the success of M. tuberculosis as an intracellular
pathogen is its ability to survive in macrophages by disrupting phagolysosome
biogenesis. The major route of entry for M. tuberculosis into macrophages is still
a matter for discussion, but most likely involves a number of surface receptors,
including complement receptors and C-type lectins, such as the mannose
receptor [86-88].

Upon entry into the macrophage, the nature of the M.

tuberculosis phagosome is well understood, and can be characterized by
incomplete luminal acidification and the absence of mature lysosomal hydrolases
[18]. The block in phagolysosome biogenesis occurs between the maturation
stages controlled by the GTP-binding proteins Rab5 (early endosomal) and Rab7
(late endosomal) [89]. The mycobacterial phagosome maintains access to early
endosomal contents, including transferrin-bound iron, through Rab5-mediated
processes, but does not acquire late endosomal or lysosomal components [8991]. Many Rab5 effectors are recruited to the mycobacterial phagosome, while
early endosomal autoantigen 1(EEA1) is displaced from it [92]. EEA1 interacts
directly with Rab5 [93] and binds to phosphatidylinositol-3-phosphate (PI3P).
PI3P is generated on organellar membranes by hVPS34, the only type III
phosphatidylinositol-3-kinase (PI3K) [93, 94]. Although retained on phagosomes
containing dead mycobacteria, PI3P is continuously eliminated from those
containing live bacilli [95].

This indicates that the phagosomes retaining PI3P

continue toward maturation and elimination of mycobacteria.

Therefore,

preventing the development of the phagolysosome is crucial for the survival of
Mycobacterium tuberculosis.
13

Several mycobacterial factors have been shown to regulate different
aspects of the phagolysosome biogenesis block and affect pathogenesis.

The

MTB-derived glycophospholipids phosphatidylinositol mannoside (PIM) and
lipoarabinomannan (LAM) are able to insert into host endomembranes and traffic
within infected cells [96]. Whereas LAM blocks calcium- and PI3K-dependent
phagosome maturation [92, 97, 98], PIM stimulates fusion of early endosomes
with the mycobacterial phagosome, permitting acquisition of nutrients [20]. MTB
also secretes an acid phosphatase, sapM, which removes any PI3P that may be
generated past the LAM block [95].

It is likely that additional mycobacterial

factors target host cell effectors to influence, either directly or indirectly, the
intracellular and extracellular environment [99, 100].

One example is the

inhibition of MHC class II antigen processing that results from the interaction
between mycobacterial factors and the Toll-like receptor (TLR) family [101].
Furthermore, recent reports indicate that the Mycobacterium tuberculosis zmp1
gene products suppress inflammasome activation and IL-1β production,
increasing mycobacterial virulence and survival in murine macrophages [102].
Therefore, Mycobacterium tuberculosis virulence factors are essential to host
manipulation and survival of mycobacteria.
1.4.2. IFN-γ promotes phagosome maturation
In addition to its value in the innate response, IFN-γ is also important for
phagosome

maturation.

Numerous

studies have shown that priming

macrophages and dendritic cells with IFN-γ prior to infection increases
intracellular killing of mycobacteria [103, 104]. This killing appears to be directed
by

both

nitric

oxide

synthase

2
14

(NOS2)-dependent

and–independent

mechanisms.

In mice, IFN-γ-induced expression of NOS2 restricts M.

tuberculosis replication via the generation of NO.

However, NOS2-/- mice

infected with M. tuberculosis survive significantly longer than mice lacking IFN-γ,
IFN-γ R1 or STAT1, through which IFN-γ signals, indicating the existence of IFNγ-dependent, NOS2-independent immunity against M. tuberculosis [105]. One
effector in this response is the GTPase Irgm1 (previously called LRG-47), which
has specific anti-mycobacterial actions [105]. However, the precise role of Irgm1
in the response to mycobacterial infection is not yet clear.

The success of

mycobacteria is accomplished by a phagosome maturation block while still
allowing fusion with transferrin-containing endosomes, consequently maintaining
a habitable environment that promotes survival [104, 106].

However, IFN-γ

activates macrophages to overcome this phagosome maturation block [47, 107].
Following activation with IFN-γ, Irgm1 is recruited to the mycobacterial
phagosome, but in Irgm1-/- mice phagosome maturation is impaired [105]. The
role of Irgm1 on the phagosome remains unknown. This demonstrates IFN-γ is a
pleiotropic cytokine that is critical for innate immunity against mycobacteria.
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1.5.

Autophagy and the innate immune response to mycobacteria
Autophagy is a fundamental homeostatic mechanism for cell survival that

maintains a balance between synthesis, degradation, and recycling of cellular
products. In autophagy, cells sequester discrete portions of the cytoplasm and
deliver them to lysosomes for degradation [108, 109]. This process removes
damaged or surplus organelles such as leaky mitochondria and excess
peroxisomes and, by degrading long-lived cytoplasmic macromolecules during
periods of starvation, promotes cell survival [110].

During autophagy, an

isolation membrane, the phagophore, surrounds portions of the cytoplasm to
form a double-membrane organelle referred to as an autophagosome.

The

autophagosome then fuses with late endosomes or lysosomes, forming an
autophagolysosome, where the captured cytoplasmic material is degraded [108,
111] (Figure 1.2).

Autophagy has also been shown to play a role in innate

immunity against intracellular pathogens, including Epstein-Barr Virus [85],
Shigella flexneri [112], Salmonella typhimurium [113], Toxoplasma gondii [114],
and Mycobacterium tuberculosis [115].

In addition, autophagy has been

implicated in adaptive immunity, by promoting endogenous antigen processing
and presentation on MHC class II [85, 116-118]. Therefore, autophagy is an
important player in cellular homeostasis and in the protection against intracellular
pathogens.
As a multistep process, autophagy begins following induction with
sequestration of a damaged organelle or a portion of cytoplasm by a nascent
autophagosomal structure called the isolation membrane (phagophore) (Figure
1.2). The phagophore is enlarged during the elongation stage by the addition of
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new membrane of undefined origin, but suspected to come from the endoplasmic
reticulum [119] or a combination of sources including Golgi and endosome [120,
121]. The isolation membrane eventually closes to form an autophagosome.
The autophagosome is differentiated from the conventional phagosome by the
presence of a double membrane (two lipid bilayers) and intra-lumenal cytosolic
content including membranes originating from the confined organelles.

A

subsequent fusion of autophagosomes with lysosomes, referred to as flux or
maturation, results in a degradative compartment known as the autolysosome
(Figure 1.3).
Atg8, also known as LC3, has been a fundamental tool to study
autophagy, especially as it is recruited to the autophagosome in the initiation step
(Figure 1.2). Phagophore enlargement and wrapping around its target in the
elongation stage require two specialized ubiquitination-like protein conjugation
systems, including E1 activation and E2 conjugation enzymes but apparently not
needing an E3 ligase. Atg12 is initially conjugated to Atg7, which acts as an E1activating enzyme, and then gets transferred to the E2-like conjugating enzyme
Atg10. This intermediate presents Atg12 to be conjugated to Atg5 (in mouse)
[110]. The Atg5-12 conjugate, stabilized in a noncovalent complex with Atg16,
triggers oligomerization on the outside membrane of the growing phagophore.
The Atg5-12/16 complex stimulates a second conjugation system, whereby LC3
undergoes conversion from its free C-terminus state (LC3-I) to its C-terminally
lapidated form (LC3-II) covalently modified by phosphatidylethanolamine. The
lipidated LC3-II localizes to the membrane on both sides of a growing
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phagophore.

Upon autophagosome closure, sealing the typical double-

membrane organelle, Atg5-12/16 and LC3 (delipidated by Atg4) dissociate from
the outer autophagosomal membrane and get recycled. The LC3 associated
with the lumenal membrane remains trapped in the autophagosome but is
degraded during maturation, which involves fusion with late endosomal and
lysosomal organelles (Figure 1.2). LC3 lipidation and LC3-II association with
autophagosomal membranes provide the basis for two frequently employed
assays of autophagy [122]: (i) autophagosome formation can be scored by
immunofluorescence microscopy as a transition of LC3 from its diffused cytosolic
to a membrane-associated, punctate intracellular distribution and (ii) the LC3-I to
LC3-II conversion can be monitored by immunoblotting.
Autophagy is dependent on the generation of PI3P by the type III PI3K,
hVPS34, during initiation and maturation of the autophagosome. PI3P is also
generated on phagosomes destined for fusion with the lysosome [95] This led
our group to investigate whether the induction of autophagy in M. tuberculosisinfected macrophages could reverse the mycobacteria-induced phagosome
maturation block. In a model system using M. tuberculosis variant bovis BCG
and the murine macrophage cell line RAW 264.7, induction of autophagy by
starvation or with rapamycin increased acidification of mycobacterial phagosome
and promoted maturation of the phagolysosome [115]. These effects could be
inhibited by the addition of 3-methyladenine (3-MA) and wortmannin, both
inhibitors of PI3Ks commonly used to inhibit autophasome formation. Following
induction of autophagy, BCG can be seen by electron microscopy in vacuoles
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containing partially degraded internal membranes, a characteristic of maturing
autophagosomes [123-125]. In addition, BCG showed increased colocalization
with microtubule-associated protein 1 light chain 3 (MAP-LC3, or LC3) and
beclin, both associated with autophagy [115]. Moreover, the survival of both
BCG and virulent M. tuberculosis in macrophages (RAW 264.7 cells and primary
murine and human macrophages) was inhibited after induction of autophagy with
rapamycin or by starvation [115]. Thus, autophagy promoted the elimination of
M. tuberculosis by diverting the mycobacterial phagosome to an autophagic
vacuole, which in turn, fused with the lysosomes, overcoming the M.
tuberculosis-induced phagolysosome biogenesis block. Therefore, this suggests
that autophagic killing of Mycobacterium tuberculosis may be essential in innate
defense.
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Figure 1.2: Stages of Autophagy.
Autophagy follows a series of steps regulated by autophagy-related (Atg)
proteins. The first step involves the formation of an isolation membrane, or
phagophore, which envelops the target until it fuses with itself to form an
autophagosome, with a double membrane. The autophagosome fuses with
lysosome to become an autolysosome. Elongation is dependent on the Atg12
conjugation system, in which Atg12 forms a complex with Atg5 and Atg16, which
in turn triggers lipidation of LC3 I to form the membrane-bound LC3-II (PE). The
Atg5-Atg12-Atg16 complex and LC3-II are recycled, while LC3-II on the luminal
membrane remains and is degraded in the autolysosome.
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Autophagy can be modulated by pharmacological agents, cytokines, and
other immunological signals [126-128].

Rapamycin is an agent that induces

autophagy through inhibition of TOR, a conserved Ser and Thr kinase that
regulates cell growth and metabolism in response to growth factors, energy
inputs, and nutritional demands [129]. TOR integrates various inputs; its
activation stimulates anabolic processes and biomass production, whereas its
inhibition enhances catabolic processes, including autophagy. Another example
of this system in action is demonstrated by amino acid starvation, which also
leads to inhibition of TOR and induction of autophagy. Conversely, TOR can be
activated by growth factors via the Akt (also known as PKB) pathway, resulting in
the inhibition of autophagy [129]. In some cases, withdrawal of growth factors
from cells is sufficient for induction of autophagy, even in the presence of
adequate nutrients [130]. However, even in the presence of adequate nutrients
the cells die more rapidly when autophagy is blocked, suggesting that autophagy
is a survival mechanism in these cells [130]. Positive regulators of autophagy
include the Th1 cytokines IFN-γ and TNF-α [115, 123, 131].

These diverse

immunological signals demonstrate the complexity of the autophagic process.
1.5.1. Th1 cell-mediated response and autophagy
The protective role of IFN-γ against mycobacteria has been associated
with autophagy [115, 128], indicating that this process is an important effector
mechanism of the Th1 response [115, 123, 131]. The mechanism by which Th1
cell-mediated/IFN-γ-response induces autophagy in macrophages is not yet fully
understood.

However, it is clear that Irgm1 is involved in this process.

Transfection of murine macrophages with Irgm1 promotes the formation of
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autophagosomes, while siRNA knockdown of Irgm1 inhibits IFN-γ-induced
autophagosome formation [115, 128]. The human ortholog of Irgm1, IRGM also
participates in autophagy. Although IRGM is not induced by IFN-γ, siRNA
knockdown of IRGM in human macrophages inhibits autophagosome formation
and

maturation

of

BCG-containing

phagosomes,

thereby

promoting

mycobacterial survival [128]. The extent to which autophagy contributes to IFNγ-induced phagosome maturation in macrophages infected with mycobacteria
still remains unknown. However, siRNA knockdown of Beclin 1, a key regulator
of autophagosome formation, completely abrogates the effect of IFN-γ on
phagosome-lysosome fusion in infected murine RAW264.7 macrophages [132],
indicating that autophagy may be responsible for the IFN-γ-induced phagosome
maturation in these cells. These data suggest autophagy plays a vital role in the
Th1 response to eliminate mycobacteria.
TNF-α is an important factor in the protective immune response to M.
tuberculosis, as it is essential for the formation and maintenance of the
granuloma [133]. Moreover, TNF-α induces apoptosis of mycobacteria-infected
macrophages, depriving the mycobacteria of their niche cell [134] and packaging
mycobacterial antigens in apoptotic vesicles for uptake and presentation by
dendritic cells [135, 136]. Numerous studies also indicate that TNF-α may be
important in the modulation of autophagy. Autophagic elimination of Toxoplasma
gondii occurs in infected macrophages following ligation of CD40, coupled with
exogenous or autocrine TNF-α signaling [114, 126]. In addition, autophagy has
been observed in T lymphoblastic leukemic cell lines at an early stage of TNF-α-
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induced cell death [137]. Expression of the autophagy genes LC3 and Beclin 1 is
induced in human atherosclerotic vascular smooth cells following treatment with
TNF-α.

This effect is dependent on the activation of the Jun kinase (JNK)

pathway [138]. Furthermore, TNF-α might also promote autophagy by inhibiting
activation of the Akt pathway [138], as siRNA-mediated knockdown of Akt
induces autophagy in murine macrophages [132]. Activation of the Akt pathway
inhibits autophagy through the activation of mTOR. In MCF-7 human breast
cancer cells, TNF-α-induced autophagy is dependent on ERK1/2 signaling since
inhibition of ERK signaling results in greater sensitivity to TNF-α-induced cell
death [139]. In Ewing sarcoma cells, TNF-α-induced autophagy is inhibited by
activation of NF-kB and is dependent on the production of reactive oxygen
species [127]. Mycobacterium tuberculosis can inhibit TNF-α-induced apoptosis
by activating NF-kB and enhancing the production of soluble TNF receptor 2
[140]. These may also represent strategies to inhibit TNF-α-induced autophagy.
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1.5.2. Th2 cell-mediated response and autophagy
While IFN-γ and TNF-α stimulate autophagy, resulting in the killing of
Mycobacterium tuberculosis, the cytokines IL-4 and IL-13, associated with Th2
responses, are considered less protective in mycobacterial disease [70]. In the
human colonic epithelial cell line HT-29 (responsive to IFN and TNF), IL-13 is a
potent inhibitor of starvation-induced autophagy [141, 142].

IL-13 stimulates

tyrosine phosphorylation of an adaptor molecule, insulin receptor substrate, that
in turn facilitates coupling of the receptor to type I PI3K (p85p110) (Figure 1.3).
Both IL-4 and IL-13 signal through IL-4Rα, which forms a heterodimer with
gamma common (γc) chain (for the IL-4 receptor) or the IL-13Rα1 (for the IL-13
receptor) [143]. Ligation of these receptor complexes results in signaling via the
insulin receptor substrate (IRS)-1/2 and STAT6 pathways [143]. While STAT6 is
involved in IL-4 and IL-13-induced gene expression, IRS-1/2 signaling activates
the type I phosphatidylinositol 3-kinase (PI3K). Type I PI3K (unlike type III PI3K
hVPS34) acts as an inhibitory PI3K in autophagy, since it leads to the activation
of Akt and TOR, downregulators of autophagy [141, 142, 144] (Figure 1.3).
However, it should be noted that these cytokines could influence the response to
M. tuberculosis (and other pathogens) through other mechanisms, such as
inhibition of the inducible nitrogen oxide (iNOS) expression [145] or indirectly
through inhibition of Th1 responses [69, 99].

The predominantly Th1

environment within the lungs of patients with active tuberculosis should promote
intracellular killing of mycobacteria; however, some reports indicate there is a
higher Th2 response in anergic patients and those with more severe pulmonary
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tuberculosis [146, 147].

As such, IL-4 and IL-13, released by macrophages

infected with virulent strains of Mycobacterium tuberculosis [70, 148, 149] could
act in an autocrine manner to inhibit the autophagic process.

These data

suggest that autophagy, as well as being a potentially important antimycobacterial response in macrophages, may be modulated by Th1 and Th2
cytokines.

25

IL-4

IFN-

IL-13

 c or

IL-13R1

IL-4R

PIP 3/PDK1

Jak1

IFNGR

IRS-1/2

Akt

p85

p70S6K

p110
I4R

STAT6

?

PI3K

mTOR
4E-BP1

Irgm1
(LRG-47

)

AUTOPHAGY

?

Figure 1.3. Opposing Effects of IFN-γ and IL-4/IL-13 in Autophagy Induction
Via Akt Pathway.
Following ligation of the IL-4/IL-13 receptor, the insulin receptor substrate (IRS
1/2) interacts with the phosphorylated IL-4R motif of the IL-4Rα via Jak1. Type I
PI3K and PDK1 are recruited to the complex, leading to the formation of
phosphoinositides (including PIP3), which results in Akt phosphorylation.
Through phosphorylation of the tuberous sclerosis protein 1 and 2 complex
(TSC1/2), Akt activates mammalian target of rapamycin (mTOR), which inhibits
autophagy. Inhibition of mTOR, such as by rapamycin, induces autophagy. IFN-γ
is a positive regulator of autophagy. These opposing roles of IFN-γ and IL-4/IL-13
suggest that Th1/Th2 balance could affect the ability of macrophages to eliminate
Mycobacterium tuberculosis by autophagy.
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1.6. Hypothesis
Macrophages represent the first line of defense against Mycobacterium
tuberculosis. The Th1 cytokine IFN-γ brings about the inhibition of mycobacterial
growth in macrophages; in contrast, the Th2 cytokines, IL-4 and IL-13, facilitate
the survival of mycobacteria.
immunity against mycobacteria.

Autophagy plays an important role in innate
IL-4 and IL-13 signal through the Akt-TOR

cascade, known to inhibit autophagy, and STAT-6 pathways.

Excessive

induction of IL-13 has been shown in macrophages infected with hypervirulent
strains of M. tuberculosis; this induction of IL-13 is believed to modify the host
cellular immune response.
I hypothesize that the Th2 cytokines, IL-4 and IL-13, inhibit the autophagic
control of Mycobacterium tuberculosis in macrophages. This study investigates
the roles of IL-4 and IL-13 in autophagy in macrophages, in the context of
Mycobacterium tuberculosis infection.
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2. MATERIALS AND METHODS
2.1. Materials
Unless otherwise stated, reagents were from Sigma (St. Louis, MO).
Recombinant murine and human IL-4 and IL-13 were purchased from R & D
Systems. Rabbit polyclonal antibody against CD63 was from Santa Cruz
Biotechnology, rabbit polyclonal antibody against LC3 was from T. Ueno and E.
Kominami. pEGFP-LC3 was from T. Yoshimori and GFP-LC3 transgenic mice
were from N. Mizushima. Tdtomato-LC3 was from G. Bjorkoy.
2.2. Methods
2.2.1. Cells and bacterial cultures
Murine RAW264.7 macrophages were cultured in Dulbecco’s modified
Eagle’s medium (DMEM, Invitrogen) supplemented with 10% fetal bovine serum
(FBS) and L-glutamine (full-nutrient medium). The human monoblastic cell lines,
U937 and THP-1, were maintained in RPMI- 1640 (Invitrogen) with 10% FBS, Lglutamine, and HEPES. Before use, U937 and THP-1 cells were differentiated
with PMA (100 nM) for 24–72 h. Mycobacterium bovis BCG was grown in
Middlebrook 7H9 broth with 0.5% Tween, 0.2% glycerol, and albumindextrosecatalase supplement (BD Diagnostics, Franklin Lakes, NJ, USA).
Primary human monocyte-derived macrophages (MDMs) were isolated and
cultured from buffy coats by density gradient centrifugation on Ficoll-Paque Plus
(GE Healthcare). PBMCs were allowed to adhere to gelatin-coated plates for at
least 1 h, washed so that nonadherent cells could be removed, and cultured in
RPMI-1640 with 10% human human AB serum for 24 h. After this time, cells
were lifted, counted, and plated on tissue-culture plastic or glass coverslips for 5–
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7 days. Bone marrow-derived macrophages (BMMs) were isolated and cultured
as described.
2.2.2. Flow cytometry
After blocking with seroblock (AbD Serotec), RAW264.7 cells were stained
with rat anti-mouse CD124 (IL-4Ra)-PE (BD) for 30 min on ice. U937 and THP-1
cells were blocked with human serum (10%) and stained first with anti-human
CD124 for 30 min on ice, then with anti-mouse IgG1-PE (BD) for 30 min on ice.
The cells were analyzed on a BD FACScaliber, and data were processed with
CellQuest software.
2.2.3. Induction of autophagy
Autophagy was induced either by amino acid starvation, in which cells
were incubated for 2 hr in Earle’s balanced salt solution (EBSS) or by treatment
with IFN-γ (200 U/ml) for 24 h [115].
2.2.4. Macrophage transfection
RAW264.7 and U937 cells were transfected by nucleoporation as
previously described [150]. In brief, cells were harvested after 2–3 days in culture
and resuspended in 100 µl of the appropriate electroporation buffer (Amaxa
Biosystems) with 5–10 µg plasmid DNA or 1.5 µg siGENOME SMARTpool siRNA
or siCONTROL nontargeting siRNA (Dharmacon) and nucleofected with Amaxa
Nucleofector apparatus. After electroporation, cells were cultured in full nutrient
medium for 24 h before use.
2.2.5. Fluorescence confocal microscopy
Cells were cultured on glass coverslips, fixed in 2% paraformaldehyde for
20 min at room temperature, permeabilized, and blocked in PBS with 0.5%
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Tween 20, 1% BSA, and 2% goat serum for 30 min at room temperature. Cells
were incubated with primary antibody for 1 h and then with secondary antibody
for an additional 1 h. Alternatively, cells were incubated with Lysotracker Red
DND-99 (LT, Invitrogen) for 2 h prior to and during incubation with mycobacteria.
For

labeling

of

acidic,

lipid-rich

vacuoles,

cells

were

incubated

with

monodansylcadaverine (MDC, 50 mM) for 15 min prior to fixing. Bone marrow
macrophages expressing GFP-LC3 were fixed with 2% paraformaldehyde for 10
min, permeabilized with 0.2% saponin for 5 min, blocked for 30 min, and
incubated with rabbit polyclonal antibodies against GFP (Abcam) overnight for
visualization of the GFP-LC3 fusion protein (GFP fluorescence in BMMs isolated
from these transgenic mice is sporadic, and GFP antibody is routinely used for
visualization of GFP-LC3.). Slides were incubated with a secondary anti-mouse
fluorescein isothiocyanate-conjugated antibody. Coverslips were mounted onto
glass slides with Permafluor Aqueous mounting medium (Thermo Scientific,
Waltham, MA, USA) and analyzed on a Zeiss LSM510 META laser-scanning
confocal microscope.
2.2.6. Immunoblotting
Cells were washed in PBS and lysed 1 h in buffer containing 10 mM Tris
HCl, 150mM NaCl, 0.5% deoxycholate, 2mM EDTA,2% NP-40, 1mM PMSF, and
protease inhibitor cocktail (Roche Applied Science). A total of 50 µg of protein
was loaded and separated on a 12% or 15% SDS polyacrylamide gel (BioRad)
and transferred to nitrocellulose. The membrane was blocked in 5% milk or 3%
BSA in PBS/Tween 20 (0.1%) and probed with primary antibodies overnight at
40C. After washing with PBS/Tween, the blot was probed with HRP-conjugated
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secondary antibody for 1 h at room temperature. Staining was revealed with
SuperSignal West Dura Extended Duration Substrate (Pierce). ImageJ (NIH)
was used for gel analyses.
2.2.7. Phagolysosome maturation and mycobacterial-survival assays
For phagocytosis of mycobacteria, macrophages were incubated with
Texas red-labeled BCG, GFP-BCG, or Mycobacterium tuberculosis strain H37Rv
for 15–30 min, washed, and incubated for an additional 2 h, in the presence of
starvation media, in the presence or absence of cytokines as indicated. After
staining the fixed cells for the lysosomal marker CD63 (LAMP3), confocal
microscopy was used so that the percentage of CD63-positive mycobacterial
phagosomes from at least 100 cells could be recorded. For mycobacterialsurvival assays, RAW cells or MDM were infected with BCG or H37Rv for 1 h,
washed, and incubated for an additional 2 hr with starvation media and cytokines
as indicated. Cells were washed with PBS and lysed with distilled water. Serial
dilutions of lysates were made, and 5 ml aliquots were inoculated on Middlebrook
7H10 agar plates supplemented with oleic acid–albumin–dextrose–catalase (BD).
Plates were sealed and incubated for 2 weeks at 37oC, and colonies were
counted from dilutions yielding 10–50 visible colonies. Data are expressed as
colony-forming units per ml (cfu/ml).
2.2.8. Statistical analysis
Data are presented as means ± SEM (approximately three independent
experiments); p values (Student’s t test; two-tailed) are relative to the control,
unless otherwise specified.
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3. RESULTS
3.1. IL-4 and IL-13 inhibit starvation-induced autophagy
Induction of autophagy in the murine RAW264.7 and human U937
monocyte or macrophage cell lines was monitored with morphometric analysis
after the formation of pEGFP-LC3-labeled [122] autophagosomes (≥ 1 µm). LC3
is the mammalian equivalent of yeast Atg8, a specific marker that translocates
from the cytosol to autophagosomal membranes [122]. Amino acid starvation
resulted in a significant increase in the number of pEGFP-LC3+ puncta per cell
(Figures 3.1 and 3.2).

Translocation of cytosolic LC3 to autophagosomal

organelles was also detected by 4D live confocal microscopy [150-152] in
macrophages transfected with tdTomato-LC3 [153] (Movie SM1). Amino acidstarvation-induced formation of LC3 puncta was abrogated with the addition of 3MA (Figure 3.3), a classical inhibitor of autophagy [154]. Both IL-4 and IL-13
signal through IL-4Rα [143]. After ascertaining the expression of IL-4Rα by flow
cytometry (Figure 3.4), IL-4 and IL-13 were added to macrophages induced for
autophagy by amino acid starvation.

Either one of the Th2 cytokines tested

abrogated autophagy, as shown by inhibition of pEGFPLC3+ puncta formation in
both RAW and U937 cells (Figures 3.1 and 3.2).
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A

B

Figure 3.1: Inhibition of starvation-induced autophagy by IL-4 and IL-13 in
murine macrophage cell line RAW264.7.
(A) Murine RAW264.7 cells were transiently transfected with pEGFP-LC3, amino
acid- and serum-starved for 2 hr with or without IL-4 or IL-13 (30 ng/ml), and
analyzed by confocal microscopy. (B) The number of large (≥1 µm) LC3 puncta
per cell were quantified. Data are presented as means ± SEM; *p < 0.05 and †p
≥ 0.05; n = 3. Scale bars represent 5 µm. (Courtesy of Dr. James Harris).
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A

B

Figure 3.2: Inhibition of starvation induced autophagy by IL-4 and IL-13 in
human macrophage-like cell line U937.
(A) Human U937 cells were transiently transfected with pEGFP-LC3, amino acidand serum-starved for 2 hr with or without IL-4 or IL-13 (30 ng/ml), and analyzed
by confocal microscopy. (B) The number of large (≥1 µm) LC3 puncta per cell
were quantified. Data are presented as means ± SEM; *p < 0.05 and †p ≥ 0.05; n
= 3. Scale bars represent 5 µm.
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B

Figure 3.3. Induction of Autophagosome Formation by Starvation.
(A) Murine RAW264.7 cells were transiently transfected with pEGFP-LC3, amino
acid- and serum-starved for 2 hr with or without 10 mM 3-methyladenine (3-MA)
and analyzed by confocal microscopy. Treatment with 3-MA inhibits puncta
formation. (B) The number of large (≥1 µm) LC3 puncta per cell were quantified.
Data are presented as means ± SEM; ** p < 0.01, † p ≥ 0.05. Scale bars
represent 5 μm. (Courtesy of Dr. James Harris).
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Figure 3.4. Flow cytometry analysis of IL-4rα surface expression.
Macrophage cell lines used in the study were tested for IL-4Rα surface
expression. There was no positive staining with the antibody isotype control.
RAW 264.7 cells frequently showed two populations of IL-4Rα expression (IL4Rαhigh and IL-4Rαlow) and were enriched for IL-4Rαhigh by cell sorting prior to
use, when necessary.
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Similar results were obtained with primary bone marrow-derived
macrophages (BMMs) from GFP-LC3 transgenic mice [155] (Figures 3.5A and
3.5B). A titration of IL-4 and IL-13 in RAW264.7 cells showed that at 0.3 ng/ml,
both cytokines still exerted their effects, albeit IL-4 was losing some of its potency
at the lowest concentration tested (Figure 3.6A).
The inhibitory effects of IL-4 and IL-13 on starvation-induced autophagy
were independently confirmed by an assay that measures conversion of LC3-I
(nonlipidated form with lower electrophoretic mobility) to LC3-II (LC3 form Cterminally

lipidated

by

phosphatidylethanolamine,

electrophoretic mobility) with immunoblots [122].

displaying

higher

As expected, induction of

autophagy by starvation reduced both LC3-I and LC3-II band intensity in
RAW264.7 cells (Figure 3.6B and Figure 3.7A, lanes 1 and 2) because of the
autophagic consumption of LC3 [122]. At the same time, the intensity of the
LC3-II band changed (increased) relative to the intensity of LC3-I band (Figure
3.6B and Figure 3.7A, lanes 1 and 2). When IL-4 and IL-13 were added to
starved macrophages, two changes occurred: (1) The intensity of the LC3-I band
increased (Figure 3.6B, lanes 3 and 4, relative to lane 2), indicative of a reduced
LC3-I-to-LC3-II conversion, consistent with the inhibition of autophagy induction
by IL-4 and IL-13. An increase in the LC3-I band was also observed in primary
murine BMM (Figure 3.7B). (2) The LC3-II band intensity decreased in starved
RAW264.7 macrophages treated with IL-4 and IL-13 (Figure 3.6B, lanes 3 and 4,
compared to lane 2).

This could be the result of reduced LC3-I-to-LC3-II
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conversion, in keeping with an inhibition of autophagy induction. However, in
BMM only an LC3-I increase but no LC3-II decrease was observed (Figure 3.7B).
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B

Figure 3.5. Inhibition of Starvation-Induced Autophagy by IL-4 and IL-13 in
Murine Bone Marrow Macrophages.
(A) Bone marrow macrophages (BMMs) from GFP-LC3 transgenic mice were
amino acid- and serum-starved (S) for 2 hr with or without IL-4 or IL-13 (30
ng/ml) and analyzed by confocal microscopy. (B) Quantification of large (>1 µm)
GFP-LC3 puncta per cell (within the denominator; calculations included cells
without any large puncta); n= 3. Data are represented as means ± SEM; * p <
0.01. (Courtesy of Dr. Monica Delgado).
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B

Figure 3.6. Inhibition of Starvation-Induced Autophagy by IL-4 and IL-13 in
Murine RAW264.7 Macrophages.
(A) Quantification of large (≥1 µm) LC3 puncta in RAW264.7 cells transfected
with GFP-LC3 and induced for autophagy by starvation in the presence of
decreasing concentrations of IL-4 or Il-13; n = 3 (separate slides; shown is one
out of two independent experiments). Data are presented as means ± SEM; **p <
0.01, and †p ≥ 0.05. (B) Immunnoblot analysis of LC3 lipidation state in
RAW264.7 cells starved and incubated without (none) or with IL-4 or IL-13. Full;
cells grown in full medium. Cells were amino acid- and serum-starved for 2 hr
(lanes 2–4). Actin was used as the loading control. (Courtesy of Dr. Monica
Delgado)
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The differences in LC3-II band intensity between RAW264.7 and BMM
may be the net result of differences in the rates of LC3-I-to-LC3-II conversion
versus LC3-II depletion through degradation in autolysosomes.

This was

substantiated with lysosomal and autolysosomal protease inhibitors (Figure 3.7A,
lanes 3 and 4, compared to lane 2), which, as expected, increased LC3-II
amounts by blocking its degradation both in the presence or absence of IL-4.
Consistent with the conclusion that Th2 cytokines inhibit LC3-I-to-LC3-II
conversion, IL-4 presence increased LC3-I band intensity (Figure 3.7A, lane 4
compared to lane 3). Because the presence of IL-4 did not diminish LC3-II band
levels relative to protease inhibitors alone (Figure 3.7A, lane 4 versus lane 3), as
one might expect from lower LC3-I-to-LC3-II conversion, Th2 cytokines may have
an additional effect on the fate of LC3-II by partially inhibiting its delivery to or its
degradation in autolysosomes. This conclusion is consistent with the apparent
preservation of the LC3-II band in BMM (Figure 3.7B). Of note is that IL-4 and
IL-13 did not change expression of the murine LC3 gene MAP1-LC3b under
starvation conditions (Figure 3.7C). In conclusion, IL-4 and IL-13 inhibit LC3-I-toLC3-II conversion and initiation of autophagy but may have additional effects on
the autophagic pathway; these effects become apparent when different cells are
examined.
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A

B

C

Figure 3.7. Inhibition of LC3 lipidation in Starvation-Induced Autophagy by
IL-4 and IL-13.
(A) IL-4 inhibits LC3-I to LC3-II conversion and slows down starvation-induced
LC3-II turnover in RAW264.7 macrophages. Western blot analysis of LC3
lipidation state in RAW264.7 cells, incubated in full medium (Full), or starved and
incubated without (-) or with IL-4. Where indicated, lysosomal protease inhibitors
e64d and pepstatin were added. GAPDH, loading control. (B) IL-4 and IL-13
inhibit LC3-I-to-LC3-II conversion in murine bone marrow derived macrophages.
Macrophages were induced for autophagy by amino acid and serum starvation in
the absence (None) or in the presence of IL-4 (+IL-4) or IL-13 (+IL-13). C, control
incubated in full medium. GAPDH, loading control. (C) Quantitative (q) RT-PCR
analysis of LC3b expression. Data are represented as means ± SEM; † p ≥ 0.05.
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3.2. IL-4 and IL-13 inhibit IFN-γ-induced formation of autophagosomes
Treatment of macrophages with IFN-γ promotes the formation of
autophagosomes [115, 128]. We tested whether this effect could be inhibited by
treating RAW and U937 cells with IFN-γ in combination with either IL-4 or IL-13.
In both cell types, IL-4 and IL-13 significantly reduced the number of IFN-γinduced pEGFP-LC3+ puncta per cell (Figure 3.8 and Figure 3.9). In addition, we
found that IFN-γ treatment increased the percentage of RAW cells with large
vacuoles that stained positively for monodansylcadaverine (MDC), another
marker for autophagic vacuoles [156], and this effect was inhibited by IL-4 or IL13 (Figures 3.10A and 3.10B).

By using the MDC assay, we confirmed the

effects of IL-4 and IL-13 in primary human, peripheral blood monocyte-derived
macrophages

(MDMs)

and

found,

in

titration

experiments,

a

similar

concentration-dependence pattern to that seen in murine macrophages (Figure
3.10C).
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Figure 3.8. Inhibition of IFN-γ-Induced Autophagy by IL-4 and IL-13 in
RAW264.7.
(A) Murine RAW 264.7 were transiently transfected with pEGFP-LC3 and treated
with 200 U/ml IFN-γ or IFN-γ in combination with IL-4 or IL-13 (30 ng/ml) for 24 hr
and analyzed by confocal microscopy. (B)The number of large (≥1 µm) LC3
puncta per cell were quantified. Data are presented as means ± SEM; * p < 0.05,
** p < 0.01, †p ≥ 0.05. Scale bars represent 5 μm. (Courtesy of Dr. James
Harris).
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Figure 3.9. Inhibition of IFN-γ-Induced Autophagy by IL-4 and IL-13 in U937.
(A) Human U937 cells were transiently transfected with pEGFP-LC3 and treated
with 200 U/ml IFN-γ or IFN-γ in combination with IL-4 or IL-13 (30 ng/ml) for 24
hr and analyzed by confocal microscopy. (B) The number of large (≥1 µm) LC3
puncta per cell were quantified. Data are presented as means ± SEM; * p < 0.05,
** p < 0.01, †p ≥ 0.05. Scale bars represent 5 μm.
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Figure 3.10. IL-4 and IL-13 Inhibit Autophagosome Formation in Murine and
Human Macrophages Assessed by Monodansylcadaverine Staining.
(A) Murine RAW 264.7 were treated with IFN-γ (200 U/ml) with or without IL-4 or
IL-13 (30 ng/ml) for 24 hr and stained with monodansylcadaverine (MDC) for 15
min. and were analyzed by confocal microscopy. (B) The percentage of cells with
MDC+ vacuoles were quantified. (C) Titration of IL-4 and IL-13 (concentration in
ng/ml) effects on reversing starvation-induced autophagy in human primary,
peripheral blood monocytes-derived macrophages (MDMs). Data are presented
as means ± SEM; * p < 0.05, ** p < 0.01, †p ≥ 0.05. Scale bars represent 5 μm.
(Courtesy of Dr. James Harris).

46

3.3. IL-4 and IL-13 inhibit autophagy-dependent BCG phagolysosome
maturation
Mycobacterium tuberculosis normally resides in phagosomes that do not
acquire phagolysosomal properties, such as lumenal acidification and the
presence of lysosomal hydrolases [157].

Induction of autophagy has been

shown to promote the transfer of mycobacteria into degradative autolysosomal
organelles [115]. To investigate whether IL-4 and IL-13 counteract this effect, we
examined the maturation of M. tuberculosis variant bovis BCG (BCG)
phagosomes by monitoring the late endosomal or lysosomal marker CD63.
Induction of autophagy by starvation or IFN-γ in BCG-infected RAW cells
significantly increased colocalization of GFP-BCG with CD63 (Figures 3.11A and
3.12A).

The effect of starvation-induced autophagy on BCG phagosome

maturation was inhibited by the addition of either IL-4 or IL-13 (Figures 3.11A and
3.12A). Both IL-4 and IL-13 also inhibited IFN-γ-induced phagosome maturation
in BCG-infected cells (Figure 3.12). Starvation increased phagosome maturation
in U937 cells, an effect that was inhibited with either IL-4 or IL-13 (Figure 3.13).
We also tested PMA-differentiated human THP-1 cells, by using the acidotropic
dye LysoTracker Red (LT) to visualize lysosomal compartments. As with RAW
cells, phagosome maturation was increased by either starvation (Figure 3.14A
and 3.14B) or IFN-γ (Figures 3.14A and 3.14C); this effect was inhibited by
treatment with either IL-4 or IL-13 (Figures 3.14).
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Figure 3.11. Inhibition of Starvation-Induced BCG Phagosome Maturation
by IL-4 and IL-13.
(A) Confocal images of murine RAW 264.7 macrophages infected with GFP-BCG
for 2 hr. Cells were amino acid- and serum-starved for 2 hr (during infection) with
or without IL-4 or IL-13 (30 ng/ml). After infection, cells were fixed and stained for
CD63. (B) The percent of CD63+ was quantified. Data are presented as means ±
SEM; * p < 0.05 and †p ≥ 0.05; n = 3.
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Figure 3.12. Inhibition of IFN-γ-Induced BCG Phagosome Maturation by IL-4
and IL-13.
(A) Confocal images of murine RAW 264.7 macrophages infected with GFP-BCG
for 2 hr. Cells were treated with IFN-γ (200 U/ml) for 24 hr prior to infection, with
or without IL-4 or IL-13 (30 ng/ml). After infection, cells were fixed and stained for
CD63. (B) The percent of CD63+ was quantified. Data are presented as means ±
SEM; * p < 0.05 and †p ≥ 0.05; n = 3. (Courtesy of Dr. James Harris).
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Figure 3.13. IL-4 and IL-13 Inhibit Autophagy-Induced BCG Phagosome
Maturation in Human U937 cells.
(A) Confocal images of human U937 macrophages infected with Texas-red-BCG
for 2 hr. Cells were amino acid- and serum-starved for 2 hr (during infection) with
or without IL-4 or IL-13 (30 ng/ml). After infection, cells were fixed and stained
with anti-CD63 (green). (B) The percent of CD63+ was quantified. Data are
presented as means ± SEM; * p < 0.05 and †p ≥ 0.05.
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Figure 3.14. IL-4 and IL-13 Inhibit Autophagy-Induced BCG Phagosome
Maturation in Human THP-1 Cells.
(A) Representative confocal images of PMA-differentiated human THP-1
monocytes infected with GFP-BCG for 2 hr. Cells were amino acid- and serumstarved for 2 hr (during infection), or pretreated with IFN-γ for 24 hr, with or
without IL-4 or IL-13 (30 ng/ml), in the presence of LysoTracker red (red
fluorescence). The percent of LysoTracker (LT)+ during starvation (B) and IFN-γ
(C) treatments were quantified. Data are presented as means ± SEM; * p < 0.05
and †p ≥ 0.05. (Courtesy of Dr. James Harris).
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Phagosome maturation was autophagy dependent, as demonstrated by
siRNA knockdown of Beclin 1, a critical mammalian autophagy factor [158]
(Figures 3.15A-C).

Although RAW cells transfected with scrambled siRNA

showed an increase in BCG phagosome maturation in response to starvation
(Figures 3.15A and 3.15D) or IFN-γ (Figures 3.15B and 3.15D), cells treated with
Beclin 1 siRNA did not, demonstrating that these responses are dependent on
functional autophagic machinery.

In the presence of full-nutrient media,

treatment of RAW macrophages with IL-4 or IL-13 had no effect on the
colocalization of CD63 with either live or heat-killed BCG phagosomes (Figure
3.16).

Thus, these Th2 cytokines do not inhibit mycobacterial phagosome

maturation under normal conditions but rather specifically inhibit autophagydependent maturation.
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Figure 3.15. Starvation- and IFN-γ-Induced BCG Phagosome Maturation is
Autophagy Dependent.
(A) Quantitative analysis of CD63+ BCG phagosomes that were in murine
RAW264.7 macrophages transiently transfected with either nontargeting
(scrambled) siRNA or Beclin 1 siRNA and that were amino acid- and serumstarved for 2 hr. (B) CD63+ BCG phagosomes in RAW264.7 cells transiently
transfected with scrambled or Beclin 1 siRNA and treated with IFN-γ (200 U/ml)
for 24 hr. Data are presented as means ± SEM; *p < 0.05, **p < 0.01, and †p ≥
0.05; n = 3 for (A) and n = 6 for (B). (C) Immunoblot confirmation of Beclin 1
knockdown by siRNA. (D) Immunofluorescence panels of BCG colocalization
with the late endosomal marker CD63, exemplifying the data in (A) and (B).
CD63 is shown in green; BCG is shown in red.
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Figure 3.16. IL-4 and IL-13 Do Not Affect Phagosome Maturation in the
Absence of Autophagy.
(A) Co-localization of CD63 with Texas-red labeled BCG was measured in RAW
264.7 cells incubated with heat-killed (dark bars) or live (light bars) BCG for 2 hr
in the presence of IL-4 or IL-13 (30 ng/ml). (B) RAW cells incubated with IL-4 or
IL-13 for 24 hr prior to infection with live BCG for 2 Hr. (Courtesy of Dr. James
Harris).
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3.4. IL-4 and IL-13 inhibit autophagic phagosome maturation in primary
human cells
To confirm that IL-4 and IL-13 inhibit autophagy-induced effects on
mycobacterial phagosomes in human primary macrophages, we tested whether
IL-4 and IL-13 influenced autophagy-induced mycobacterial phagosome
maturation. Human peripheral blood monocyte-derived macrophages (MDMs)
were infected with BCG and induced for autophagy by starvation. The effect of
starvation-induced autophagy on mycobacterial phagosome maturation was
decreased by the addition of either IL-4 or IL-13 (Figures 3.17A and 3.17B).
Similarly, both IL-4 and IL-13 had an inhibitory effect on IFN-γ-induced
mycobacterial phagosome maturation (Figures 3.17A and 3.17B). These results
validate in human primary macrophages the conclusion that Th2 cytokines
counteract

autophagy

in

its

ability

phagolysosome.
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Figure 3.17. IL-4 and IL-13 Counteract Autophagy-Induced Phagosome
Maturation in Primary Human Macrophages.
(A) Primary human macrophages derived from peripheral blood monocytes were
infected with BCG. Transfer of mycobacteria to phagolysosome dependent on
autophagy was scored with the acidotropic dye LysoTracker (LT). Autophagy
was induced for 2 hr by starvation or by treatment with 200 U/ml human IFN-γ.
Cells were incubated in the absence or presence of 30 ng/ml of human IL-4 or IL13, as indicated. (B) Quantification of experiments. Data are presented as means
± SEM; *p < 0.05 and †p ≥ 0.05; n = 3 (three independent donors). (Courtesy of
Dr. James Harris).
56

3.5. IL-4 and IL-13 inhibit autophagy-dependent killing of intracellular
mycobacteria
To determine whether IL-4 and IL-13 affect autophagic elimination of
mycobacteria [115], we infected RAW cells with BCG and induced autophagy by
amino acid starvation for 2 hr. Induction of autophagy decreased BCG survival in
RAW cells (Figure 3.18A).

Addition of IL-4 or IL-13 to the starvation media

abrogated this effect (Figure 3.18A). Similar results were obtained when survival
of virulent M. tuberculosis H37Rv was tested with starvation or IFN-γ used as
autophagy agonists (Figures 3.17B and 3.18C). Figure 3.18D shows that these
relationships hold true in primary macrophages because IL-4, used as an
example, abrogated killing of virulent M. tuberculosis H37Rv by starvationinduced autophagy in murine BMMs. These findings demonstrate that IL-4 or IL13 inhibit autophagy-induced killing of mycobacteria by macrophages.
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Figure 3.18. IL-4 and IL-13 Inhibit Autophagy-Dependent Killing of M.
tuberculosis in Murine Macrophages.
(A) Murine RAW264.7 macrophages were infected with BCG for 1 hr and were
amino acid- and serum-starved with or without IL-4 or IL-13 (30 ng/ml) for 2 h.
Cells were washed and lysed for viability determination and survival expressed
as a percentage of the control. (B) Murine RAW264.7 macrophages were
infected with virulent M. tuberculosis H37Rv for 1 h and were amino acid- and
serum-starved with or without IL-4 or IL-13 (30 ng/ml) for 2 h. Cells were washed
and lysed for viability determination. (C) Murine RAW264.7 macrophages were
either untreated or treated with 200 U/ml of m-IFN-γ for 24 h prior to infection
with M. tuberculosis H37Rv for 1 hr with or without IL-4 or IL-13 (30 ng/ml) for 2
h. Cells were washed and lysed for viability (cfu) determination. Data are
presented as means ± SEM, *p < 0.05, **p < 0.01, and †p ≥ 0.05; n = 3. (D) IL-4
inhibits autophagy-dependent killing of M. tuberculosis H37Rv in primary murine
macrophages. Murine bone marrow macrophages were infected with virulent M.
tuberculosis (strain H37Rv) for 1 h and were amino acid- and serum-starved with
or without IL-4 (30 ng/ml) for 2 h. Mycobacterial viability (colony counts) is
expressed as a percentage of the control. (Courtesy of Dr. Sharon Master).
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3.6. Inhibition of starvation-induced autophagy by IL-4 and IL-13 is Akt
dependent
To determine the signaling involved in the actions of IL-4 and IL-13 on
autophagy in macrophages, we examined whether the Akt pathway, known to
activate TOR and inhibit autophagy [129], was involved.

In both RAW264.7

(Figure 3.19A) and U937 (Figure 3.19B) macrophages, IL-4 and IL-13 increased
phosphorylation of Akt under starvation conditions (Figure 3.19B, top two panels
and graph). We next tested the activity of TOR, a key negative regulator of
autophagy (when TOR is active, autophagy is inhibited) on the basis of reports
that TOR is activated by Akt [129].

We investigated TOR activation by

monitoring phosphorylation of p70 S6 kinase (S6k) and 4E-BP1, two TOR
substrates commonly used as indicators of its activation state [129]. Treatment
of U937 cells with IL-4 or IL-13 increased phosphorylation of S6k (Figure 3.19B).
In RAW264.7 macrophages, IL-4 and IL-13 treatment increased phosphorylation
of 4E-BP1 under starvation conditions in a dose-dependent manner (Figure
3.20B and Figure 3.21A). A finer-resolution analysis of 4E-BP1 phosphorylation
was carried out next. TOR induces 4E-BP1 inactivation via multiple hierarchical
phosphorylations [159]. A fine-resolution immunoblot analysis can be used for
revealing 4E-BP1 hypophosphorylated α and β forms, and hyperphosphorylated
γ form, resolved in the order of their decreasing electrophoretic mobility. Active
Akt elicits 4E-BP1(γ) hyperphosphorylation through TOR activity [159].

Our

analyses revealed that IL-4 and IL-13 treatment specifically increased
phosphorylation of 4E-BP1(γ), under starvation conditions, in primary murine
BMMs (Figure 3.20A and Figure 3.21B), and in human MDMs (Figure 3.22).
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Figure 3.19. IL-4 and IL-13 Activate TOR Via the Akt Pathway.
(A) Immunoblot analysis of Akt phosphorylation in RAW264.7 macrophages
amino acid- and serum starved for 2 hr with or without IL-4 or IL-13 (30 ng/ml).
(B) Immunoblot analysis of Akt (top two blots) and p70S6K (bottom two blots)
phosphorylation in human U937 macrophages in full media or amino acid- and
serum- starved for 2 h with or without IL-4 or IL-13 (30 ng/ml). Ratios of
phosphoproteins (p-Akt or p-p70 S6 k) to total corresponding protein (Akt or p70
S6 k) are shown in graphs to the right.
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Figure 3.20. IL-4 Activates TOR Via the Akt Pathway in Murine
Macrophages.
(A) Immunoblot analysis of 4E-BP1 hierarchical phosphorylation in murine bone
marrow macrophages (BMMs) starved and treated with IL-4 for 40, 60, and 120
min. Graph shows the ratio of 4E-BP1(γ) vs. 4E-BP1(β) (n = 2) (B) Immunoblot
analysis of 4E-BP1 phosphorylation in murine RAW 264.7 macrophages starved
and treated for 2 hr with varying concentrations of IL-4. Graph shows the ratio of
phosphorylated vs. total 4E-BP1 (n = 3).
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Figure 3.21. IL-4 and IL-13 Activate TOR Via the Akt Pathway in Murine
Macrophages.
(A) Immunoblot analysis of 4E-BP1 phosphorylation in murine RAW 264.7
macrophages starved and treated for 2 hr with varying concentrations of IL-13.
Graphs show the ratio of phosphorylated vs. total 4E-BP1 (n = 3). (B)
Immunoblot analysis of 4E-BP1 in murine bone marrow macrophages (BMMs).
Graph shows the ratio of 4E-BP1(γ) vs. 4E-BP1(β) (n = 2).
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Figure 3.22. IL-4 and IL-13 Activate TOR Via the Akt Pathway in Primary
Human Macrophages.
Immunnoblot analysis of human monocyte-derived macrophages (MDMs)
starved for 2 hr with or without IL-4 or IL-13. Graph show (n = 2; one out of two
experiments with similar results) the intensity ratios of p-4E-BP1(γ) to p-4EBP1(β) bands.
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Furthermore, a time course of 4E-BP1 showed that IL-4 exerted its effects
by increasing 4E-BP1(γ) hyperphosphorylation at 2 hr but had no discernible
effects at earlier time points (Figure 3.20A), consistent with other effects
measured in our study. These results demonstrate that IL-4 and IL-13 activate
the Akt pathway in macrophages, resulting in the activation of TOR and inhibition
of starvation-induced autophagy.
To establish the role of Akt in the IL-4- and IL-13-induced inhibition of
autophagy in macrophages, we knocked down Akt1 and Akt2 with siRNA in vitro
(Figure 3.23A).

Compared with the control samples (scrambled siRNA),

knockdown of Akt1 and Akt2 in RAW macrophages increased autophagy,
monitored by LC3+ vacuole formation (Figures 3.23B and 3.23C), indicating that
basal levels of autophagy are controlled, at least in part, by baseline Akt
activation. Double knockdown of Akt1 and Akt2 in RAW cells abrogated the
effects of IL-4 and IL-13 on starvation-induced autophagy (Figures 3.23B and
3.23C). In BCG-infected RAW cells, knockdown of Akt1 and Akt2 also inhibited
the effects of IL-4 and IL-13 on starvation-induced transfer of BCG to
autophagosomes (Figures 3.24A and 3.24C).
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Figure 3.23. IL-4 and IL-13 Inhibit Starvation-induced Autophagy Via Akt
Pathway.
(A) Immunoblot confirmation of Akt 1 and Akt2 knockdown in RAW264.7 cells
transiently transfected with control (scrambled) or Akt 1 and Akt 2 siRNA. (B)
Quantification of large (≥1 µm) pEGFP-LC3 puncta per cell in RAW 264.7
macrophages transiently transfected with pEGFP-LC3 and either scrambled
siRNA or Akt 1 + Akt 2 siRNA and starved for 2 hr with or without IL-4 or IL-13.
(C) Representative confocal images of RAW cells transiently transfected with
pEGFPLC3 in combination with scrambled or Akt 1 and Akt 2 siRNA and amino
acid- and serum-starved for 2 h with or without IL-4 or IL-13 (30 ng/ml).
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Figure 3.24. IL-4 and IL-13 Inhibit Starvation-Induced Transfer of BCG to
Autophagosome Via Akt Pathway.
(A) Quantitative analysis of CD63+ BCG phagosomes in RAW264.7 cells
transiently transfected with scrambled siRNA or Akt 1 + Akt 2 siRNA and infected
with BCG for 2 hr. Infected cells were amino acid- and serum-starved with or
without IL-4 or IL-13. (B) Percentage of CD63+ BCG phagosomes in RAW264.7
cells transiently transfected with scrambled siRNA or Akt1 + Akt 2 siRNA, treated
with IFN-γ with or without IL-4 or IL-13 for 24 hr, and infected with BCG for 2 hr.
(C) Representative confocal images of RAW cells transfected with Akt 1 and Akt
2 siRNA, infected with Texas red-labeled BCG and starved for 2 h with or without
IL-4 or IL-13. CD63 staining was revealed with Alexa-488 (green).
(Courtesy of Dr. James Harris).
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3.7. Inhibition of IFN-γ-induced autophagy is STAT6 dependent
In contrast to the effects with IL-4 and IL-13 on starvation-induced
autophagy, a double knockdown of Akt1 and Akt2 with siRNA had no effect on
the inhibition of IFN-γ-induced phagosome maturation by IL-4 and IL-13 (Figure
3.24B), suggesting that the suppressive effects of these Th2 cytokines on the
activation by IFN-γ involved alternative or additional pathways, independent of
Akt signaling. Akt3 was detectable only at very low amounts in these cells, and
its expression was not affected by knockdown of Akt1 and Akt2 (data not shown).
We therefore tested whether the inhibitory effect of IL-4 and IL-13 on IFN-γinduced autophagy was regulated via a different pathway.

IL-4 and IL-13

receptors, in addition to signaling via the Akt pathway, are more commonly
known for their activation of STAT6 [143]. Thus, we tested whether STAT6 was
required for Th2 cytokine inhibition of autophagy activation by IFN-γ.

When

STAT6 was knocked down (Figure 3.25A), IL-13 could no longer suppress IFN-γinduced

autophagosome

formation

in

macrophages

(Figures

3.25B-E).

Collectively, our data on IL-4 and IL-13 inhibition of starvation- and IFN-γ-induced
autophagy demonstrate that Th2 cytokines can employ either of the signaling
pathways associated with ligation of the IL-4 and IL-13 receptors to exert this
effect. Suppression of starvation-induced autophagy occurs through activation of
Akt, whereas STAT6 is needed for suppression of IFN-γ-induced autophagy.
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Figure 3.25. IL-13 Inhibits IFN-γ-Induced Autophagy Via STAT6 Pathway.
(A) Immunoblot confirmation of STAT6 knockdown in RAW264.7 macrophages
transiently transfected with control (scrambled) or STAT6 siRNA. Polyclonal antiSTAT6 rabbit antibodies (Bethyl Laboratories) were used for immunoblotting. (BE) Th2 inhibition of IFNγ-dependent autophagy is STAT6 dependent: (B and C)
display confocal-microscopy images and quantification of GFP-LC3 puncta
formation in response to IFN-γ, with or without IL-13, in cells treated with control
(scrambled) siRNA. (D and E) display images and quantification of GFP-LC3
puncta formation in response to IFN-γ, with or without IL-13, in cells treated with
control STAT6 siRNA. Data in all graphs presented as means ± SEM; n ≥ 3; *p <
0.05, **p < 0.01, and †p ≥ 0.05. (Courtesy of Dr. Esteban A. Roberts).
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4. DISCUSSION
The major result of the present study is that the Th2 cytokines IL-4 and IL13 inhibited the autophagy-induced elimination of mycobacteria by murine and
human macrophages.

This inhibition was accomplished by the cytokines

impairing the autophagic transfer of mycobacteria from an immature phagosome
to the autolysosome; this action prevented the elimination of intracellular bacilli
by autophagy. This study also demonstrated that the effect of IL-4 and IL-13 on
starvation-induced autophagy is dependent on signaling via the Akt pathway.
The finding that the Th2 cytokines depend on Akt signaling was not surprising
since published studies have reported that IL-13 stimulates the Akt pathway,
which activates TOR, a repressor of autophagy [141, 142]. However, what was
unexpected was the finding that the effect of IL-4 and IL-13 on IFN-γ-induced
autophagy was independent of Akt; instead, it depended on signaling via the
STAT6 pathway.
Autophagy plays a role in the response to a number of intracellular
pathogens [85, 112-115]. Mycobacterium tuberculosis has developed the ability
to inhibit maturation of the macrophage phagosome to promote its survival [157].
However, our lab has previously shown that the induction of autophagy in
Mycobacterium tuberculosis-infected macrophages led to an increase in
phagosome maturation and a decrease in intracellular survival of the bacilli [115].
Consequently, autophagy represents a mechanism by which macrophages are
able to overcome the phagosome maturation block imposed by mycobacteria,
leading ultimately to enhanced mycobacterial elimination.
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4.1. Autophagy-mediated clearance of Mycobacterium tuberculosis and
Th1-Th2 polarization
After phagocytosis by macrophages, bacterial pathogens are trapped
within the phagosome and subsequently degraded by lysosomes [160].
Mycobacteria escape elimination by arresting maturation of the phagosome in
which they are trapped. However, amino acid starvation and IFN-γ stimulate
autophagy in macrophages to overcome this phagosome maturation block and
increase elimination of mycobacteria. In this study, we analyzed the effects of
the Th2 cytokines IL-4 and IL-13 in murine and human macrophage cell lines
during the autophagic response. The maturation of the autophagosome when
macrophages were starved or exposed to IFN-γ, as determined by the
accumulation of LC3-II on the autophagosome and transfer of bacteria to the
autophagosome, was hindered when the macrophage was stimulated with the
Th2 cytokines.

The concentrations of IL-4 and IL-13 used in our titration

experiments were in the range of the in vivo and ex vivo tissue levels of these
cytokines under a variety of conditions [161-163], including studies involving
mycobacterial antigens [164]. Therefore, this study showed that the microbicidal
effect of autophagy is abrogated by the cytokines IL-4 and IL-13 through the
inhibition of mycobacterial phagosome maturation.
4.2. Effects of IL-4 and IL-13 in starvation-induced autophagy
While amino acid starvation stimulates autophagy, the Th2 cytokines IL-4
and IL-13 generated an opposing effect. In HT-29 epithelial cells, IL-13 inhibits
starvation-induced autophagy through the activation of the Akt pathway [141,
142]. The two cytokines signal through IL-4Rα, which then signal via the insulin
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receptor substrate (IRS)-1/2 [143].

IRS-1/2 signaling activates the type I

phosphatidylinositol 3 kinase (PI3K), ultimately activating the Akt pathway and
TOR [129].

The activation of TOR results in the negative regulation of

autophagy. In this study, we analyzed the effects of the Th2 cytokines IL-4 and
IL-13 in murine and human macrophage cell lines on the Akt pathway and TOR
activity during starvation-induced autophagy.

The activity of TOR decreases

when cells are starved, as determined by the decrease in phosphorylation of
TOR activation state indicators, resulting in the induction of autophagy in both
murine and human macrophages.

However, treatment with IL-4 and IL-13

increased phosphorylation of the TOR activation state indicators under starvation
conditions, suggesting the Th2 cytokines stimulate TOR activity in macrophages.
The in vitro double knockdown of Akt1 and Akt2 in macrophages negated the
effects of IL-4 and IL-13 on starvation-induced autophagy, thus increasing
autophagic activity, as monitored by LC3+ vacuole formation.

This data

demonstrated that stimulation with IL-4 and IL-13 increased Akt and TOR activity,
suggesting the effect of IL-4 and IL-13 on starvation-induced autophagy is
dependent on signaling via the Akt pathway.
4.3. Effects of IL-4 and IL-13 on IFN-γ-induced autophagy
IL-4 and IL-13 inhibit IFN-γ-induced autophagy independent of the Akt and
TOR pathway. Unlike the Akt-dependent inhibitory effects of IL-4 and IL-13 on
starvation-induced autophagy demonstrated in this study, this investigation
revealed that the Th2 cytokines inhibit autophagy by signaling through the STAT6
pathway. The effects of STAT6 on autophagy by IL-4 and IL-13 may depend on
a number of pathways.

One such pathway involves the increase of the
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antiapoptotic and also recognized inhibitors of autophagy, Bcl-2 and Bcl-XL
protein levels by STAT6 [165] [166, 167]. The inhibition of autophagy occurs as
Bcl-2 and Bcl-XL interact with the BH3 domain of Beclin 1 under normal steadystate growth conditions, whereas its dissociation from Bcl-2 mediates autophagy
[166, 167]. Beclin 1 interacts with several activators (Liang et al, 2006; Fimia et
al, 2007; Takahashi et al, 2007), which positively regulate autophagy by
promoting the activation of the PI(3)K protein, VPS34, and the formation of
autophagosomes.
IFN-γ has also been shown to increase the expression of DAPK [168],
which recent reports indicate phosphorylates Beclin 1 at its BH3 domain;
subsequently, this phosphorylation promotes the dissociation of Beclin 1 from
Bcl-XL, resulting in the induction of autophagy [169]. The IL-4 and IL-13 inhibition
of IFN-γ-induced autophagy via STAT6, observed in this study, is supported by
the findings that Bcl-2 and Bcl-XL association with Beclin 1 blocks stimulation of
autophagy [166], and the rapid induction of STAT6 via IL-4 and IL-13 stimulation
may increase Bcl-XL availability [165].

This surprise finding suggests STAT6 as

an immunologically relevant regulator of autophagy. Furthermore, it elucidates
how Th2 cytokines counter autophagy-dependent protection against intracellular
pathogens provided by Th1 polarization.
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Figure 4.1. A Proposed Model for IL-4 and IL-13 Regulation of Autophagy.
(A) IL-4 and IL-13 inhibit starvation-induced autophagy by activating Akt and
TOR, two negative regulators of autophagy. (B) IFN-γ-induced autophagy is
inhibited by the activation of STAT6. The Bcl-XL association with Beclin blocks
stimulation of autophagy. IFN-γ activates DAPK, which phosphorylates Beclin.
This phosphorylation promotes the dissociation of Beclin from Bcl-XL, resulting in
the induction of autophagy. The activation of STAT6, via IL-4 and IL-13
stimulation, may increase the Bcl-XL association with Beclin, thus inhibiting
autophagy.
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4.4. Cytokines in the immune response to mycobacteria
In human tuberculosis, analyses of the patterns of T cell cytokines have
met with conflicting conclusion. Patients with pulmonary tuberculosis in general
have lymphocytes in their lungs with a Th1 phenotype producing IFN-γ [59, 60].
Nevertheless, lung tissue from patients with cavitary tuberculosis has been
observed to display a Th2 lymphocyte subset phenotype relative to the Th1
subsets demonstrated in non-cavitary disease [59]. The Th2 phenotype shows a
relationship of a higher production of IL-4 in the periphery of patients with
cavitary disease [64], suggesting that IL-4 levels possibly indicate severity of
disease. Another study has shown that lymphocytes obtain from the cavitary wall
secrete more IFN-γ when stimulated with mycobacterial antigens than cells from
non-progressive tuberculoma tissues [170], indicating a higher Th1 phenotype.
In some cases, granulomas can be positive for IFN-γ and IL-4 [171, 172]. Some
studies have reported a Th1 response in the periphery of patients with mild
pulmonary tuberculosis and Th2 responses in patients lacking immunity or those
with more severe disease [146, 147]. The phenotype of infected macrophages
and dendritic cells within the granuloma is less well defined, but in vitro studies in
human peripheral blood monocytes have demonstrated that virulent strains of
tuberculosis preferentially up-regulate the production of Th2 cytokines such as
IL-4, IL-5, IL-10, and IL-13, while non-virulent strains induce a Th1-type response
[70, 148, 149]. Thus, it is possible that in the typically Th1 environment of the
granuloma, local secretion of IL-4 and IL-13 could specifically impair the
response of infected macrophages to IFN-γ.

However, secretion of anti-

inflammatory cytokines like IL-4, TGF-β, and IL-10 may be necessary to dampen
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the pathological effects of a prolonged or excessive Th1 response, although in
progressive tuberculosis disease IL-4 can actually increase immunopathology
[68].
Mycobacterium tuberculosis HN878 and other W/Beijing isolates induce
IL-13 expression, which, along with IL-4 is associated with Th2 responses, are
considered to be more virulent than others [70, 173]. M. tuberculosis strains
differ in their epidemiological features including rates of active disease among
exposed/infected individuals [174].

Significantly, these effects have recently

been linked to specific cytokine profiles, with excessive induction of IL-13 in
macrophages infected with hypervirulent strains of M. tuberculosis (HN878 and
W/Beijing) [70]. In contrast, CDC1551 induces more IL-12 and other molecules
associated with phagocyte activation and Th1 protective immunity.

These

differences have been ascribed to mycobacterial lipids [173] and modulation of
cytokine production [70]. This differential response mediated by mycobacterial
lipids, with phenolic glycolipid (PGL) being a candidate [173].

These and

additional considerations suggest the phenolic glycolips of Mycobacterium
tuberculosis virulent strains increase levels of Th2 cytokines to inhibit autophagic
activity and enhance their survival.
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4.5. Limitations
The present study contains certain inherent limitations that need to be
addressed. First, the study was accomplished on cultured cells. Consequently,
the monocytes/macrophage cells were analyzed secluded from the dynamics
existing in their microenvironment and may not reflect accurate in vivo cell
behavior.

Second, in this study, we did not specifically examine alternative

activation of macrophages by IL-4 and IL-13 [69]; instead, the focus was on the
effects of short-term treatment of 2 hours in combination with IFN-γ. Treatment
of macrophages with IL-4 or IL-13 for 6 days has been shown to enhance fluidphase pinocytosis and mannose receptor-mediated endocytosis through
activation of phosphatidylinositol 3 kinase; both cytokines increase tubularvesicle formation at pericentriolar sites under the plasma membrane, concurrent
with decreased particle sorting to the lysosomes [175]. Although these previous
observations could explain the inhibitory effects of IL-4 and IL-13 on
autophagolysosome formation, IL-4 and IL-13 had no effect on BCG phagosome
maturation in the absence of starvation- or IFN-γ-induced autophagy,
demonstrating that the effects observed in our experiments are autophagy
specific. A study on the effects of alternative activation of macrophages with Th2
cytokines, in the context of autophagy, may be difficult to address because
prolonged autophagy can lead to type-II programmed cell death, and most cells
will downregulate this process to ensure their survival [167].
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4.6. Conclusion and future directions
This study shows that Th2 cytokines IL-4 and IL-13 inhibited autophagy
and

undermined

the

ability

of

macrophages

to

eliminate

intracellular

mycobacteria. Th2 cytokines inhibited both physiologically and immunologically
induced autophagy in murine and human monocytes and macrophage.
Furthermore, these cytokines inhibited autophagy-dependent maturation of the
mycobacterial phagosome averting elimination of mycobacteria. These findings
have ramifications in Th1-Th2 polarization of the immune response to
Mycobacterium tuberculosis. By antagonizing autophagy, IL-4 and IL-13 inhibit
Th1-dependent protection against mycobacteria, possibly explaining why Th2
cytokines antagonize protection against other intracellular microbes, such as
Listeria moncytogenes and Legionella pneumophila.

The regulation of

autophagy may represent a critical aspect of Th1-Th2 polarization in the host
response to intracellular pathogens. Thus, the balance of Th1 and Th2 cytokines
is clearly critical in the host response to Mycobacterium tuberculosis. Based on
Th1 inducing autophagy and Th2 dampening that response, this study sheds
more light on this dichotomy.
Higher level of IL-4 may indicate severity of disease in patients with
cavitary tuberculosis [64].

Therefore, in individuals with a mixed Th1-Th2

response to mycobacteria, it may be more beneficial to block the Th2 component
than to boost the Th1 response. This would be especially important if there is an
already adequate Th1 component.

The possibility of restraining the Th2

response by stimulating suitable types of regulatory T cells has been pursued in
studies of allergic disorders, where much larger Th2 responses are present [176].
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Although the importance of autophagy in the elimination of Mycobacterium
tuberculosis has been established in vitro, existing studies have not determined
to what extent autophagy contributes to the immune response against
mycobacteria in vivo. Therefore, it would be of great relevance to study the
autophagic status of alveolar macrophages and dendritic cells, inside the
granuloma and its periphery, during pulmonary tuberculosis. The role of various
different cytokines on this process may prove insightful, particularly those of
potential importance in the innate immune response and granuloma formation,
such as IL-10 and TGF-β. The answers to these questions could advance the
evolutionary arms race of the host to prevail in the fight against Mycobacterium
tuberculosis.
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5. APPENDICES
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Appendix A. T Helper 2 Cytokines Inhibit Autophagic Control of Intracellular
Mycobacterium tuberculosis.
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